Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Sanofi-Aventis S.A. (SNYNF)
Sanofi-Aventis S.A. (SNYNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 14.69
  • Price/Book 2.10
Trade SNYNF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.4500 +3.54%
on 02/14/24
97.2500 -3.70%
on 02/22/24
-2.9375 (-3.04%)
since 02/01/24
3-Month
90.4500 +3.54%
on 02/14/24
106.0000 -11.65%
on 01/12/24
-0.2500 (-0.27%)
since 12/04/23
52-Week
86.1174 +8.75%
on 10/27/23
114.9000 -18.49%
on 04/25/23
-0.5000 (-0.53%)
since 03/02/23

Most Recent Stories

More News
Informatica soars on its AI-powered data management cloud growth

Enterprise cloud data management software provider Informatica Co. (NASDAQ: INFA) saw its shares surge 23% on its impressive Q3 2023 earnings report. The compa

F : 12.72 (+2.17%)
PG : 159.61 (+0.48%)
INFA : 32.05 (-1.26%)
AMZN : 177.56 (-0.37%)
INTC : 45.66 (+4.20%)
SNYNF : 93.6500 (-0.90%)
SNY : 47.16 (-0.27%)
SAN : 4.12 (-0.72%)
SHEL : 62.85 (-1.12%)
SHEL.LN : 2,460.500 (-0.57%)
RTX : 89.91 (+0.12%)
Pfizer and Sanofi shares fall, which one to scoop up?

Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows

PFE : 25.89 (-2.63%)
SNY : 47.16 (-0.27%)
SNYNF : 93.6500 (-0.90%)
SAN : 4.12 (-0.72%)
MDCO : 84.90 (-0.07%)
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

SDGR : 25.25 (-5.82%)
GOOG : 134.15 (-2.85%)
NVDA : 848.93 (+3.18%)
SAN : 4.12 (-0.72%)
SNY : 47.16 (-0.27%)
SNYNF : 93.6500 (-0.90%)
RXRX : 12.31 (-3.90%)
EXAI : 6.02 (-7.67%)
BMY : 50.90 (+0.02%)
Exscientia is the Sniper of the AI Drug Discovery Industry

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

EXAI : 6.02 (-7.67%)
GGRGF : 17.0000 (-16.05%)
SNYNF : 93.6500 (-0.90%)
SNY : 47.16 (-0.27%)
RXRX : 12.31 (-3.90%)
BMY : 50.90 (+0.02%)
NVDA : 848.93 (+3.18%)
SDGR : 25.25 (-5.82%)
SFTBF : 59.2000 (+0.44%)
DarioHealth is an AI-Powered Digital Therapeutics Play

DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic

DRIO : 1.7300 (-13.28%)
AMWL : 1.0300 (-2.83%)
CVS : 73.87 (+0.04%)
DXCM : 122.30 (+0.46%)
SNY : 47.16 (-0.27%)
SAN : 4.12 (-0.72%)
SNYNF : 93.6500 (-0.90%)
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing

SINGAPORE, Dec 6, 2022 - (ACN Newswire) - Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National...

GSK.LN : 1,667.800 (+0.24%)
0A87.LN : 14.460 (-0.75%)
SNY : 47.16 (-0.27%)
GSK : 42.43 (+0.95%)
TAK : 14.48 (-0.55%)
SNYNF : 93.6500 (-0.90%)
TKPHF : 28.5000 (-1.16%)
Sanofi (SNYNF) Received its Third Buy in a Row

After UBS and Jefferies gave Sanofi (Other OTC: SNYNF) a Buy rating last month, the company received another Buy, this time from J.P. Morgan. Analyst Richard Vosser maintained a Buy rating on Sanofi today...

SNYNF : 93.6500 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 95.1833
2nd Resistance Point 95.0467
1st Resistance Point 94.7733
Last Price 93.6500
1st Support Level 94.3633
2nd Support Level 94.2267
3rd Support Level 93.9533

See More

52-Week High 114.9000
Fibonacci 61.8% 103.9050
Fibonacci 50% 100.5087
Fibonacci 38.2% 97.1124
Last Price 93.6500
52-Week Low 86.1174

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar